Toggle Main Menu Toggle Search

ePrints

Browsing publications by Claire Schwab

Newcastle AuthorsTitleYearFull text
Claire Schwab
Professor Christine Harrison
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia2019
Dr Paul Sinclair
Dr Sarra Ryan
Dr Matthew Bashton
Shaun Hollern
Rebecca Hanna
et al.
SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain2019
Dr Lina Hamadeh
Dr Amir Enshaei
Claire Schwab
Professor Christine Harrison
Professor Anthony Moorman
et al.
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL2019
Dr Paul Sinclair
Dr Helen Blair
Dr Sarra Ryan
Dr Lars Buechler
Joanna Cheng
et al.
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 212018
Claire Schwab
Professor Christine Harrison
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling2018
Dr Britta Vormoor
Professor Gareth Veal
Melanie Griffin
Professor Julie Irving
Lynne Minto
et al.
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia2017
Claire Schwab
Professor Christine Harrison
Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia2017
Dr Amir Enshaei
Professor Christine Harrison
Dr Sujith Samarasinghe
Claire Schwab
Professor Anthony Moorman
et al.
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia2017
Claire Schwab
Dr Lucy Chilton
Professor Anthony Moorman
Professor Christine Harrison
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?2017
Professor Anthony Moorman
Claire Schwab
Professor Christine Harrison
Dr Sujith Samarasinghe
Use of minimal residual disease assessment to redefine induction failure in pediatric acute lymphoblastic leukemia2017
1234567